Schizophrenia is a complex and chronic brain disorder affecting approximately 2.8 million adults in the US. Dr. Gustavo Alva, Medical Director at ATP Clinical Research (Gus Alva MD – ATP Clinical Research) and Patrick, an adult living with schizophrenia have information about a new FDA approved treatment.
